Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum to “Recomendaciones del Grupo Español de Trabajo en enfermedad de Crohn y colitis ulcerosa (GETECCU) sobre la reservoritis en la colitis ulcerosa. Parte 2: Tratamiento” [Gastroenterología y Hepatología 2020;43(10):649-658].
Barreiro-de Acosta M, Marín-Jimenez I, Rodríguez-Lago I, Guarner F, Espín E, Ferrer Bradley I, Gutiérrez A, Beltrán B, Chaparro M, Gisbert JP, Nos P; en representación de GETECCU. Barreiro-de Acosta M, et al. Among authors: nos p. Gastroenterol Hepatol. 2021 Apr;44(4):320. doi: 10.1016/j.gastrohep.2021.02.001. Epub 2021 Feb 25. Gastroenterol Hepatol. 2021. PMID: 33642094 Free article. English, Spanish. No abstract available.
Long-term durability of response to adalimumab in Crohn's disease.
Chaparro M, Panés J, García V, Merino O, Nos P, Domènech E, Peñalva M, García-Planella E, Esteve M, Hinojosa J, Andreu M, Muñoz F, Gutiérrez A, Mendoza JL, Barrio J, Barreiro-de M, Vera I, Vilar P, Cabriada JL, Montoro MA, Aldeguer X, Saro C, Gisbert JP. Chaparro M, et al. Among authors: nos p. Inflamm Bowel Dis. 2012 Apr;18(4):685-90. doi: 10.1002/ibd.21758. Epub 2011 May 25. Inflamm Bowel Dis. 2012. PMID: 21618353
[Peripheral arterial thromboembolism in Crohn's disease].
Ferrer I, Benavent G, Bastida G, Arnau MÁ, Iborra M, Beltrán B, Aguas M, Hinojosa J, Nos P. Ferrer I, et al. Among authors: nos p. Gastroenterol Hepatol. 2013 Jan;36(1):30-4. doi: 10.1016/j.gastrohep.2012.04.011. Epub 2012 Jun 29. Gastroenterol Hepatol. 2013. PMID: 22749513 Spanish.
Oral locally active steroids in inflammatory bowel disease.
Nunes T, Barreiro-de Acosta M, Marin-Jiménez I, Nos P, Sans M. Nunes T, et al. Among authors: nos p. J Crohns Colitis. 2013 Apr;7(3):183-91. doi: 10.1016/j.crohns.2012.06.010. Epub 2012 Jul 10. J Crohns Colitis. 2013. PMID: 22784947 Review.
Effectiveness of infliximab after adalimumab failure in Crohn's disease.
Chaparro M, Andreu M, Barreiro-de Acosta M, García-Planella E, Ricart E, Domènech E, Esteve M, Merino O, Nos P, Peñalva M, Gisbert JP. Chaparro M, et al. Among authors: nos p. World J Gastroenterol. 2012 Oct 7;18(37):5219-24. doi: 10.3748/wjg.v18.i37.5219. World J Gastroenterol. 2012. PMID: 23066316 Free PMC article.
Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome.
García-Bosch O, Gisbert JP, Cañas-Ventura A, Merino O, Cabriada JL, García-Sánchez V, Gutiérrez A, Nos P, Peñalva M, Hinojosa J, García-Planella E, Muñoz F, Calvet X, Panés J. García-Bosch O, et al. Among authors: nos p. J Crohns Colitis. 2013 Oct;7(9):717-22. doi: 10.1016/j.crohns.2012.10.004. Epub 2012 Nov 8. J Crohns Colitis. 2013. PMID: 23142005
176 results